Association between SNP rs4986790 and COVID-19 infection severity among Baghdad patients
Keywords:COVID-19, SARS-CoV-2, polymorphism, Toll-like receptor 4, SNP rs4986790
Introduction and Aim: COVID-19, an infectious disease caused by the SARS-CoV-2 coronavirus, is distinguished by the manifestation of severe acute respiratory syndrome. Toll-like receptors (TLRs) are signaling molecules that play crucial roles in the innate immune system through their recognition of pathogen-associated molecular patterns in diverse microorganisms, including coronaviruses. The primary aim of this research was to investigate the plausible association between the TLR4 gene Asp299Gly polymorphism and the degree of infection severity among individuals who contracted COVID-19 in Baghdad, Iraq.
Materials and Methods: This cross-sectional prospective study was carried out in Baghdad to investigate the Asp299Gly polymorphism within the TLR4 gene in a cohort of 90 patients diagnosed with Covid-19. Out of the total number of patients, 45 individuals exhibited symptoms indicative of a moderate infection, while the remaining 45 patients presented with a severe illness. The Asp299Gly polymorphism was analyzed using polymerase chain reaction (PCR) technique and restriction fragment length polymorphism (RFLP).
Results: Genotyping for the Asp299Gly polymorphism showed only one among the 90 (1.1%) Covid-19 patients tested to be positive. No significant association was seen between covid-19 severity and Asp299Gly (P = 0·31) polymorphism.
Conclusion: Our study found no association between SNP rs4986790 of TLR4 gene and COVID-19 severity among Covid-19 patients in Baghdad city.
Payne, S. Family Coronaviridae. Viruses. 2017: 149-158.
Tyrrell, D.A., Bynoe, M.L., Cultivation of a novel type of common-cold virus in organ cultures. Br Med J .1965;1(5448):1467.
Khan, M., Adil, S.F., Alkhathlan, H.Z., Tahir, M.N., Saif, S., Khan, M., et al., COVID-19: a global challenge with old history, epidemiology and progress so far. Molecules. 2020;26(1):39.
Froes, F. And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nMan. Pulmonology. 2020;26(2):114-115.
Heymann, D.L., Shindo, N., WHO Scientific and Technical Advisory Group for Infectious Hazards. COVID-19. 2020: 395.
Kumar, N., Mathew, G., Huchchannavar, R. Home-based care programme (hbcp) for patients with covid-19: boon or burden during pandemic management?. Biomedicine. 2023 May 4;43(02):649-654.
Mamatha, S. D., Priya, S. A., Shashikala, L., Shivakumar, K. M., Chandrashekarappa, S. M. Assessment of the cognitive status of covid-19 patients and its correlation to blood pressure. Biomedicine. 2023 jul 20;43(3):1008-1012.
Wu, F., Zhao, S., Yu, B., Chen, Y., Wang, W., Song, Z-G., et al., A new coronavirus associated with human respiratory disease in China. Nature. 2020;579 (7798):265-269.
Rasmussen, S.B., Reinert, L.S., Paludan, S.R. Innate recognition of intracellular pathogens: detection and activation of the first line of defense. Apmis. 2009;117(5-6):323-337.
Kawai, T., Akira, S. The role of pattern recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11(5):373-384.
Miller, R.E., Belmadani, A., Ishihara, S., Tran, P.B., Ren, D., Miller, R.J., et al., Damage associated molecular patterns generated in osteoarthritis directly excite murine nociceptive neurons through Toll like receptor 4. Arthritis Rheumatol. 2015;67(11):2933-2943.
Arbour, N.C., Lorenz, E., Schutte, B.C., Zabner, J., Kline, J.N., Jones, M., et al., TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 2000;25(2):187-191.
Lorenz, E., Frees, K.L., Schwartz, D.A. Determination of the TLR4 genotype using allele specific PCR. Biotechniques. 2001;31(1):22-24.
Rasoul, L.M., Nsaif, M.M., Al-Tameemi, M.T., Al-Rubaii, B.A.L. Estimation of primer efficiency in multiplex PCR for detecting SARS-Cov-2 variants. Bionatura, 2022, 7 (3), 48.
Abbas, M.S., Ahmed, A.G., Ali, S.Q., AL-Rubaii, B.A.L. Immunological inflammatory factors in patients diagnosed with COVID-19. Biomedicine, 2023; 43(1):230-235.
Lorenz, E., Hallman, M., Marttila, R., Haataja, R., Schwartz, D.A. Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res. 2002;52(3):373-376.
Browning, B.L., Huebner, C., Petermann, I., Gearry, R.B., Barclay, M.L., Shelling, A.N., et al., Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Off J Am. Coll. Gastroenterol ACG. 2007;102(11):2504-2512.
Montes, A.H., Asensi, V., Alvarez, V., Valle, E., Ocana, M.G., Meana, A., et al., The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for Gram-negative and haematogenous osteomyelitis. Clin Exp Immunol. 2006; 143(3):404-413.
Karoly, E., Fekete, A., Banki, N.F., Szebeni, B., Vannay, A., Szabo, A.J., et al., Heat shock protein 72 (HSPA1B) gene polymorphism and Toll-like receptor (TLR) 4 mutation are associated with increased risk of urinary tract infection in children. Pediatr Res. 2007;61(3):371-374.
World J Gastroenterol WJG. 2005;11(10):1489.
Tulic, M.K., Hurrelbrink, R.J., Prele, C.M., Laing, I.A., Upham, J.W., Le Souef, P. et al., TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. J Immunol. 2007;179(1):132-140.
Reindl, M., Lutterotti, A., Ingram, J., Schanda, K., Gassner, C., Deisenhammer, F., et al., Mutations in the gene for toll like receptor 4 and multiple sclerosis. Tissue Antigens. 2003; 61(1):85-88.
Kroner, A., Vogel, F., Kolb-Mäurer, A., Kruse, N., Toyka, K. V., Hemmer, B., et al., Impact of the Asp299Gly polymorphism in the toll-like receptor 4 (tlr-4) gene on disease course of multiple sclerosis. J Neuroimmunol. 2005;165(1–2): 161-165.
Lakatos, P.L., Lakatos, L., Szalay, F., Willheim-Polli, C., Osterreicher, C., Tulassay, Z., et al., Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn’s disease: phenotype-genotype correlations.
How to Cite
Copyright (c) 2023 Biomedicine
This work is licensed under a Creative Commons Attribution 4.0 International License.